Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Spring Allergies Start Strong and Last Long As Extreme Weather Patterns Continue


News provided by

Asthma and Allergy Foundation of America

Apr 02, 2013, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Spring Allergy Capitals Report Ranks Most Challenging Cities

LANDOVER, Md., April 2, 2013 /PRNewswire-USNewswire/ -- Extreme weather patterns may contribute to a severe and long allergy season this spring, according to the Asthma and Allergy Foundation of America (AAFA). The 2013 Spring Allergy Capitals™ report released today by AAFA – the 11th year of the report – ranks the most challenging cities to live with allergies in the United States. This new list shows the increased potential for severe and prolonged allergy symptoms as spring arrives early, and as many regions of the country recover from severe storms and flooding. For specific allergy risks in 100 U.S. cities and tips on managing allergy symptoms, visit www.AllergyCapitals.com. The report is an independent research project of AAFA sponsored by DYMISTA™ (azelastine hydrochloride and fluticasone propionate), the first and only seasonal allergy spray to block histamine and treat inflammation for effective relief of seasonal allergy symptoms.

Continue Reading

(Photo: http://photos.prnewswire.com/prnh/20130402/DC86402)

"Severe weather patterns can bring higher temperatures, higher pollen levels and increased exposure to outdoor mold, resulting in spring allergies that can peak stronger and last longer," said Bill Berger, MD, Allergy and Asthma Associates of Southern California. "Too often, people with seasonal allergies suffer silently while their symptoms worsen year after year. Allergy sufferers need to learn more about allergies and visit an allergy specialist for a proper diagnosis and treatment. Often more can be done to relieve allergy symptoms that interfere with daily life."

Residents across the United States can expect more severe allergy conditions this year as an unusually wet winter and early warm temperatures lead to earlier tree pollination and higher levels of pollen and outdoor mold. Northern cities predicted to face a more challenging spring allergy season compared to one year ago include: Buffalo, NY (rising 10 spots to #15 out of 100 cities), Springfield, MA (rising from #74 to #18), Richmond, VA (rising from #46 to #22), Detroit, MI (rising from #50 to #26) and Toledo, OH (rising from #57 to #29).

"The severe allergy conditions expected in many cities across the country means more challenges for patients, and a need for powerful and effective treatment options for them to help manage their condition," said Mike Tringale, Vice-President of External Affairs at AAFA.

There is no cure for allergies. Nearly half of seasonal allergy patients are unhappy with how slowly their prescription medicines work and many patients still experience breakthrough of severe symptoms despite using a seasonal allergy medication.(1) Patients with seasonal allergies want a safe, easy-to-use medicine that completely controls their symptoms, especially if those symptoms are severe. The best way for people to manage seasonal allergies is to avoid allergy triggers like pollen and outdoor mold, get properly diagnosed, and use fast-acting, more effective medications to prevent and treat symptoms. DYMISTA™ is the first and only medicine that both reduces inflammation while also blocking histamine, one of the underlying causes of seasonal allergy symptoms.

This year's ranking shows that nasal allergies are a problem nationwide, especially in southern states. Overall, 15 of the top 25 cities on this year's ranking are in the South. These findings are consistent with research showing that spring now arrives 10 to 14 days earlier than it did just 20 years ago, bringing with it increased pollen counts.(2,3)   

Recent hurricanes, severe storms and tornadoes can also affect the severity of spring allergies. The increased presence of mold in areas damaged by floods can trigger allergic reactions. Major urban areas and locations with significant construction may also see an increased risk for severe allergies, because pollen from weeds proliferates in places with development projects. Finally, ground-level ozone pollution can affect allergy symptoms.

For 2013, Jackson, MS, claimed the top spot on AAFA's Spring Allergy Capitals ranking, followed by Knoxville, TN (#2) and Chattanooga, TN (#3). Of note, three major cities, Philadelphia, New Orleans and Dallas each climbed slightly higher in the top 25 compared with last year. "AAFA encourages the 40 million Americans who suffer from seasonal allergies to learn more, consult an allergy specialist, and insist on adequate symptom relief," said Tringale. An interactive map of 100 cities, resources about diagnosis, prevention and treatment options, resources for physicians, and more information on the study methodology are available at www.AllergyCapitals.com.

About the Research
The Spring Allergy Capitals™ ranking is an annual research and educational project of AAFA, designed to help patients recognize, prevent and safely treat allergy symptoms. Through this ranking, AAFA raises awareness of allergies and provides helpful information designed to improve the quality of life for people with allergies. AAFA and DYMISTA™ are working together this year to promote the findings of the report, educate the public about this chronic disease, and encourage people to get diagnosed and properly treated.

The Allergy Capitals™ are identified and ranked based on pollen levels, use of over-the-counter and prescription allergy medication and number of Board Certified allergists.

About AAFA
Now in its 60th year, the Asthma and Allergy Foundation of America (AAFA) is the leading nonprofit consumer and patient organization dedicated to fighting asthma and allergic diseases.  AAFA provides free information to the public, offers educational programs to consumers and health professionals, leads advocacy efforts to improve patient care, and funds research to find a cure. For more information, visit www.aafa.org.

About Dymista™
Dymista Nasal Spray is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 12 years of age and older who require treatment with both azelastine hydrochloride and fluticasone propionate for symptomatic relief.

IMPORTANT RISK INFORMATION

  • Dymista Nasal Spray can cause drowsiness. Do not drive, operate machinery, or do anything that you need to be alert for until you know how Dymista Nasal Spray affects you
  • Do not drink alcohol or take any other medicines that can cause you to feel sleepy while using Dymista Nasal Spray. This can increase your chances of having serious side effects
  • Tell your healthcare provider if you have any side effects that bother you or any side effects that do not go away
  • Tell your doctor if you are pregnant or plan to become pregnant; it is not known if Dymista Nasal Spray will harm your unborn baby
  • The most common side effects with Dymista are changes in taste, nosebleeds, and headache
  • Dymista Nasal Spray may also cause the following side effects:
    • Nasal problems. Symptoms of nasal problems include crusting in the nose, nosebleeds, runny nose, or a hole in the cartilage between your nostrils (nasal septal perforation). A whistling sound when you breathe may be a symptom of nasal septal perforation
    • Slow wound healing. If you have a sore in your nose, if you have had surgery on your nose, or if your nose has been injured, you should not use Dymista Nasal Spray until your nose has healed
    • Thrush (Candida), a fungal infection in your nose, mouth, or throat. Tell your doctor if you have any redness or white-colored patches in your nose, mouth, or throat
    • Eye problems. Some people may experience eye problems, including glaucoma or cataracts. You should have regular eye exams when using Dymista Nasal Spray
    • Immune system problems. Dymista Nasal Spray may cause problems with the way your immune system protects your body against infection.
    • Use caution when taking Dymista if you have an existing infection (eg, fungal, bacterial, viral, or parasitic). When using Dymista Nasal Spray, avoid contact with people who have contagious diseases such as chicken pox or measles. Symptoms of infection may include fever, aches and pains, chills, or feeling tired
    • Adrenal insufficiency. Adrenal insufficiency is a condition in which the adrenal glands do not make enough steroid hormones. Symptoms of adrenal insufficiency may include tiredness, weakness, nausea, vomiting, or low blood pressure
    • Slowed or delayed growth in children. A child's growth should be checked regularly when using Dymista Nasal Spray
    • These are not all of the possible side effects of Dymista Nasal Spray. For more information, ask your healthcare provider or pharmacist

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

References
(1). Harris interactive survey of U.S. adult allergy patients. Commissioned by the Asthma and Allergy Foundation of America, October 10-17, 2005.

(2). Staudt A, et al. (2010). Extreme allergies and global warming. Retrieved from http://aafa.org/pdfs/NWF_Allergies%20FINAL%20REPORT.pdf

(3). Ziska L, et al. Recent warming by latitude associated with increased length of ragweed pollen season in central North America. Pro. Natl Acad Sci 2011; doi:10.1073/pnas.1014107108

SOURCE Asthma and Allergy Foundation of America

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.